Dentsply Sirona Inc. XRAY
We take great care to ensure that the data presented and summarized in this overview for DENTSPLY SIRONA Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding XRAY
View all-
Vanguard Group Inc Valley Forge, PA20.1MShares$373 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.7MShares$347 Million0.01% of portfolio
-
First Eagle Investment Management, LLC14.2MShares$262 Million0.8% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA11.2MShares$208 Million1.21% of portfolio
-
Nuance Investments, LLC Kansas City, MO10.8MShares$201 Million11.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$196 Million0.03% of portfolio
-
Morgan Stanley New York, NY7.7MShares$143 Million0.02% of portfolio
-
Cooke & Bieler LP7.38MShares$137 Million2.04% of portfolio
-
Lazard Asset Management LLC New York, NY6.54MShares$121 Million0.26% of portfolio
-
State Street Corp Boston, MA6.46MShares$120 Million0.01% of portfolio
Latest Institutional Activity in XRAY
Top Purchases
Top Sells
About XRAY
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
Insider Transactions at XRAY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 18
2024
|
Gregory T Lucier Director |
BUY
Open market or private purchase
|
Direct |
5,000
+6.52%
|
$90,000
$18.37 P/Share
|
Nov 15
2024
|
Gregory T Lucier Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+5.88%
|
$18,000
$18.28 P/Share
|
Nov 12
2024
|
Simon D Campion President, CEO & Member of BOD |
BUY
Open market or private purchase
|
Direct |
11,306
+3.99%
|
$192,202
$17.72 P/Share
|
Nov 11
2024
|
Kevin Czerney VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,082
+35.4%
|
-
|
Oct 11
2024
|
Janet S. Vergis Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.16%
|
-
|
Oct 11
2024
|
Ilse Dorothea Wenzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.28%
|
-
|
Oct 11
2024
|
Jonathan Jay Mazelsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
80
+0.58%
|
-
|
Oct 11
2024
|
Richard C Rosenzweig EVP, Corp Dev, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
266
+0.47%
|
-
|
Oct 11
2024
|
Leslie F Varon Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.14%
|
-
|
Oct 11
2024
|
Gregory T Lucier Director |
BUY
Grant, award, or other acquisition
|
Direct |
69
+0.1%
|
-
|
Oct 11
2024
|
Betsy D Holden Director |
BUY
Grant, award, or other acquisition
|
Direct |
208
+0.54%
|
-
|
Oct 11
2024
|
Clyde Hosein Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.18%
|
-
|
Oct 11
2024
|
Robert Anthony Johnson SVP, Chief Supply Chain Office |
BUY
Grant, award, or other acquisition
|
Direct |
439
+0.46%
|
-
|
Oct 11
2024
|
Brian T Gladden Director |
BUY
Grant, award, or other acquisition
|
Direct |
83
+0.58%
|
-
|
Oct 11
2024
|
Andreas G Frank Exec VP/Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
392
+0.33%
|
-
|
Oct 11
2024
|
Andrea L. Frohning SVP, CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
71
+0.5%
|
-
|
Oct 11
2024
|
Glenn Coleman Executive VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
375
+0.42%
|
-
|
Oct 11
2024
|
Willie A Deese Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.11%
|
-
|
Oct 11
2024
|
Simon D Campion President, CEO & Member of BOD |
BUY
Grant, award, or other acquisition
|
Direct |
897
+0.34%
|
-
|
Sep 12
2024
|
Simon D Campion President, CEO & Member of BOD |
SELL
Payment of exercise price or tax liability
|
Direct |
33,729
-11.48%
|
$843,225
$25.39 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 221K shares |
---|---|
Open market or private purchase | 39.1K shares |
Payment of exercise price or tax liability | 78.3K shares |
---|